2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

被引:4875
作者
Levy, MM
Fink, MP
Marshall, JC
Abraham, E
Angus, D
Cook, D
Cohen, J
Opal, SM
Vincent, JL
Ramsay, G
机构
[1] Brown Univ, Rhode Isl Hosp, Sch Med, Med Intens Care Unit, Providence, RI 02903 USA
[2] Univ Pittsburgh, Med Ctr, Div Crit Care Med, Pittsburgh, PA USA
[3] Toronto Gen Hosp, Div Cellular & Mol Biol, Toronto, ON, Canada
[4] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
[5] McMaster Univ, St Josephs Hosp, Div Crit Care Med, Hamilton, ON L8S 4L8, Canada
[6] Univ London Imperial Coll Sci Technol & Med, Div Investigat Sci, London, England
[7] Brown Univ, Mem Hosp Rhode Isl, Sch Med, Div Infect Dis, Providence, RI 02912 USA
[8] Erasme Univ Hosp, Dept Intens Care, B-1070 Brussels, Belgium
[9] Univ Hosp, Dept Surg, Maastricht, Netherlands
关键词
sepsis; severe sepsis; septic shock; systemic inflammatory response syndrome; PIRO;
D O I
10.1097/01.CCM.0000050454.01978.3B
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: In 1991, the American College of Chest Physicians (ACCP) and the Society of Critical Care Medicine (SCCM) convened a "Consensus Conference," the goals of which Were "to provide a conceptual and a practical framework to define the systemic inflammatory response to infecton, which is a progressive injurious process that falls under the generalized term 'sepsis' and includes sepsis-associated organ dysfunction as well." The general definitions introduced as a result of that conference have been widely used in practice and have served as the foundation for inclusion criteria for numerous clinical trials of therapeutic interventions. Nevertheless, there has been an impetus from experts in the field to modify these definitions to reflect our current understanding of the pathophysiology of these syndromes. Design: Several North American and European intensive care societies agreed to revisit the definitions for sepsis and related conditions. This conference was sponsored by the SCCM, The European Society of Intensive Care Medicine (ESICM), The American College of Chest Physicians (ACCP), the American Thoracic Society (ATS), and the Surgical Infection Society (SIS). Methods. The conference was attended by 29 participants from Europe and North America. In advance of the conference, five subgroups were formed to evaluate the following areas: signs and symptoms of sepsis, cell markers, cytokines, microbiologic data, and coagulation parameters. The subgroups corresponded electronically before the conference and met in person during the conference. A spokesperson for each group presented the deliberation of each group to all conference participants during a plenary session. A writing committee was formed at the conference and developed the current article based on executive summary documents generated by each group and the plenary group presentations. The present article serves as the final report of the 2001 International Sepsis Definitions Conference. Conclusion. This document reflects a process whereby a group of experts and opinion leaders revisited the 1992 sepsis guidelines and found that apart from expanding the list of signs and symptoms of sepsis to reflect clinical bedside experience, no evidence exists to support a change to the definitions. This lack of evidence serves to underscore the challenge still present in diagnosing sepsis in 2003 for clinicians and researchers and also provides the basis for introducing PIRO as a hypothesis-generating model for future research.
引用
收藏
页码:1250 / 1256
页数:7
相关论文
共 41 条
  • [11] CYTOKINE SERUM LEVEL DURING SEVERE SEPSIS IN HUMAN IL-6 AS A MARKER OF SEVERITY
    DAMAS, P
    LEDOUX, D
    NYS, M
    VRINDTS, Y
    DEGROOTE, D
    FRANCHIMONT, P
    LAMY, M
    [J]. ANNALS OF SURGERY, 1992, 215 (04) : 356 - 362
  • [12] DOUGHTY LA, 1996, CRIT CARE MED, V109, P1033
  • [13] Alveolar and serum procalcitonin - Diagnostic and prognostic value in ventilator-associated pneumonia
    Duflo, F
    Debon, R
    Monneret, G
    Bienvenu, J
    Chassard, D
    Allaouchiche, B
    [J]. ANESTHESIOLOGY, 2002, 96 (01) : 74 - 79
  • [14] *E LILL CO, 2001, BRIEF DOC XIGRIS TRE
  • [15] Implementation of serum cardiac troponin I as marker for detection of acute myocardial infarction
    Falahati, A
    Sharkey, SW
    Christensen, D
    McCoy, M
    Miller, EA
    Murakami, MA
    Apple, FS
    [J]. AMERICAN HEART JOURNAL, 1999, 137 (02) : 332 - 337
  • [16] Serial evaluation of the SOFA score to predict outcome in critically ill patients
    Ferreira, FL
    Bota, DP
    Bross, A
    Mélot, C
    Vincent, JL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (14): : 1754 - 1758
  • [17] Gospodarowicz M, 1998, Cancer Prev Control, V2, P262
  • [18] Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis
    Harbarth, S
    Holeckova, K
    Froidevaux, C
    Pittet, D
    Ricou, B
    Grau, GE
    Vadas, L
    Pugin, J
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (03) : 396 - 402
  • [19] Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: A prospective study
    Hausfater, P
    Garric, S
    Ayed, SB
    Rosenheim, M
    Bernard, M
    Riou, B
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (07) : 895 - 901
  • [20] Extracellular phospholipases A2 in relation to systemic inflammatory response syndrome (SIRS) and systemic complications in severe acute pancreatitis
    Hietaranta, A
    Kemppainen, E
    Puolakkainen, P
    Sainio, V
    Haapiainen, R
    Peuravuori, H
    Kivilaakso, E
    Nevalainen, T
    [J]. PANCREAS, 1999, 18 (04) : 385 - 391